Literature DB >> 18722391

Characterizing intercellular signaling peptides in drug addiction.

Elena V Romanova1, Nathan G Hatcher, Stanislav S Rubakhin, Jonathan V Sweedler.   

Abstract

Intercellular signaling peptides (SPs) coordinate the activity of cells and influence organism behavior. SPs, a chemically and structurally diverse group of compounds responsible for transferring information between neurons, are broadly involved in neural plasticity, learning and memory, as well as in drug addiction phenomena. Historically, SP discovery and characterization has tracked advances in measurement capabilities. Today, a suite of analytical technologies is available to investigate individual SPs, as well as entire intercellular signaling complements, in samples ranging from individual cells to entire organisms. Immunochemistry and in situ hybridization are commonly used for following preselected SPs. Discovery-type investigations targeting the transcriptome and proteome are accomplished using high-throughput characterization technologies such as microarrays and mass spectrometry. By integrating directed approaches with discovery approaches, multiplatform studies fill critical gaps in our knowledge of drug-induced alterations in intercellular signaling. Throughout the past 35 years, the National Institute on Drug Abuse has made significant resources available to scientists that study the mechanisms of drug addiction. The roles of SPs in the addiction process are highlighted, as are the analytical approaches used to detect and characterize them.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722391      PMCID: PMC2665169          DOI: 10.1016/j.neuropharm.2008.07.036

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  143 in total

1.  Protein analysis of an individual Caenorhabditis elegans single-cell embryo by capillary electrophoresis.

Authors:  S Hu; R Lee; Z Zhang; S N Krylov; N J Dovichi
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-03-10

Review 2.  Genomics, gene expression and DNA arrays.

Authors:  D J Lockhart; E A Winzeler
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

Review 3.  CART peptides are modulators of mesolimbic dopamine and psychostimulants.

Authors:  J N Jaworski; A Vicentic; R G Hunter; H L Kimmel; M J Kuhar
Journal:  Life Sci       Date:  2003-06-27       Impact factor: 5.037

4.  A proteomics approach to identify long-term molecular changes in rat medial prefrontal cortex resulting from sucrose self-administration.

Authors:  Michel C Van den Oever; Sabine Spijker; Ka Wan Li; Connie R Jiménez; Eisuke Koya; Roel C Van der Schors; Yvonne Gouwenberg; Rob Binnekade; Taco J De Vries; Anton N M Schoffelmeer; August B Smit
Journal:  J Proteome Res       Date:  2006-01       Impact factor: 4.466

Review 5.  Microarray studies of psychostimulant-induced changes in gene expression.

Authors:  Vadim Yuferov; David Nielsen; Eduardo Butelman; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2005-03       Impact factor: 4.280

Review 6.  Neuroproteomics of the synapse and drug addiction.

Authors:  Noura S Abul-Husn; Lakshmi A Devi
Journal:  J Pharmacol Exp Ther       Date:  2006-04-27       Impact factor: 4.030

7.  Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference.

Authors:  Liu Yang; Zhong Sheng Sun; Yong-ping Zhu
Journal:  J Proteome Res       Date:  2007-04-20       Impact factor: 4.466

8.  Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal.

Authors:  Gökhan Göktalay; Sinan Cavun; Mark C Levendusky; Jonathan R Hamilton; William R Millington
Journal:  Eur J Pharmacol       Date:  2005-12-20       Impact factor: 4.432

Review 9.  "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Oluwatosin O Fatusin; Qing-Rong Liu; Carlo Contoreggi; Chuan-Yun Li; Kari Buck; John Crabbe
Journal:  Biochem Pharmacol       Date:  2007-07-25       Impact factor: 5.858

10.  Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; Bernhard Hennig; William Maragos; Michal Toborek
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

View more
  6 in total

Review 1.  Small-volume analysis of cell-cell signaling molecules in the brain.

Authors:  Elena V Romanova; Jordan T Aerts; Callie A Croushore; Jonathan V Sweedler
Journal:  Neuropsychopharmacology       Date:  2013-06-10       Impact factor: 7.853

Review 2.  Recent advances in mass spectrometry analysis of neuropeptides.

Authors:  Ashley Phetsanthad; Nhu Q Vu; Qing Yu; Amanda R Buchberger; Zhengwei Chen; Caitlin Keller; Lingjun Li
Journal:  Mass Spectrom Rev       Date:  2021-09-24       Impact factor: 9.011

3.  MALDI mass spectrometric imaging using the stretched sample method to reveal neuropeptide distributions in aplysia nervous tissue.

Authors:  Tyler A Zimmerman; Stanislav S Rubakhin; Elena V Romanova; Kevin R Tucker; Jonathan V Sweedler
Journal:  Anal Chem       Date:  2009-11-15       Impact factor: 6.986

4.  D-Alanine in the islets of Langerhans of rat pancreas.

Authors:  Nobutoshi Ota; Stanislav S Rubakhin; Jonathan V Sweedler
Journal:  Biochem Biophys Res Commun       Date:  2014-04-08       Impact factor: 3.575

5.  Comparative peptidomics analysis of neural adaptations in rats repeatedly exposed to amphetamine.

Authors:  Elena V Romanova; Ji Eun Lee; Neil L Kelleher; Jonathan V Sweedler; Joshua M Gulley
Journal:  J Neurochem       Date:  2012-09-03       Impact factor: 5.372

6.  Mass spectrometry screening reveals peptides modulated differentially in the medial prefrontal cortex of rats with disparate initial sensitivity to cocaine.

Authors:  Elena V Romanova; Ji Eun Lee; Neil L Kelleher; Jonathan V Sweedler; Joshua M Gulley
Journal:  AAPS J       Date:  2010-05-19       Impact factor: 4.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.